Search - tctmd.com

Displaying 101 - 120 of 185

Sort: Relevancy | Date

Could RAS-Inhibitor Prescription After TAVR Improve 1-Year Outcomes?

News Daily News

Could RAS-Inhibitor Prescription After TAVR Improve 1-Year Outcomes?

Yael L. Maxwell

December 10, 2018

PIONEER-HF: Sacubitril/Valsartan Safe and Effective in Acute Decompensated Heart Failure

News Conference News AHA 2018

PIONEER-HF: Sacubitril/Valsartan Safe and Effective in Acute Decompensated Heart Failure

Michael O'Riordan

November 11, 2018

Gender Gap May Be Narrowing in ACS Patients, With Mortality Advantage for Elderly Women

News Daily News

Gender Gap May Be Narrowing in ACS Patients, With Mortality Advantage for Elderly Women

October 12, 2018

EXCEL Deep Dive: Repeat Revascularization, Medical Therapy, and Anemia All Impact Patient Prognosis

News Conference News TCT 2018

EXCEL Deep Dive: Repeat Revascularization, Medical Therapy, and Anemia All Impact Patient Prognosis

Michael O'Riordan

September 21, 2018

Latest SWEDEHEART Data Show Acute MI Mortality Rates Have Stagnated

News Conference News ESC 2018

Latest SWEDEHEART Data Show Acute MI Mortality Rates Have Stagnated

September 04, 2018

Updated ESC Guidelines Introduce Concept of a Pregnancy Heart Team for Women With CVD

News Conference News ESC 2018

Updated ESC Guidelines Introduce Concept of a Pregnancy Heart Team for Women With CVD

August 31, 2018

Sobering News From Europe: CVD Risk Factors Are on the Rise or Holding Firm

News Conference News ESC 2018

Sobering News From Europe: CVD Risk Factors Are on the Rise or Holding Firm

August 27, 2018

Ten-Year Follow-up Proves Disappointing for Bilateral Arterial Grafts in ART

News Conference News ESC 2018

Ten-Year Follow-up Proves Disappointing for Bilateral Arterial Grafts in ART

August 26, 2018

Rates of Heart Failure After Acute MI Declining, Statewide Analysis Shows

News Daily News

Rates of Heart Failure After Acute MI Declining, Statewide Analysis Shows

Michael O'Riordan

April 05, 2018

Time for Guidelines to Recommend ARBs Over ACE Inhibitors?

News Daily News

Time for Guidelines to Recommend ARBs Over ACE Inhibitors?

March 29, 2018

Low BP Tied to Poor Outcomes in Hospitalized Patients With HFpEF

News Daily News

Low BP Tied to Poor Outcomes in Hospitalized Patients With HFpEF

February 20, 2018

Global Improvement in ACS Care Seen With Regional Clinical Pathway Implementation

News Conference News AHA 2017

Global Improvement in ACS Care Seen With Regional Clinical Pathway Implementation

Yael L. Maxwell

November 27, 2017

As Hypertension Sweeps China, Awareness, Treatment, and Control Remain Poor

News Daily News

As Hypertension Sweeps China, Awareness, Treatment, and Control Remain Poor

October 26, 2017

Generic ARBs Linked to Increased Adverse Events

News Daily News

Generic ARBs Linked to Increased Adverse Events

Michael O'Riordan

October 04, 2017

Study Questions Incremental Benefit of Beta-Blockers After Acute MI

News Daily News

Study Questions Incremental Benefit of Beta-Blockers After Acute MI

Michael O'Riordan

September 21, 2017

Acute MI Mortality Has Dropped to Very Low Levels in France

News Conference News ESC 2017

Acute MI Mortality Has Dropped to Very Low Levels in France

September 08, 2017

Early Cardiology Care Tied to Better Outcomes for New A-fib Patients

News Daily News

Early Cardiology Care Tied to Better Outcomes for New A-fib Patients

June 26, 2017

Debating the ARB/MI Paradox: Is It Real, or Is the Story Incomplete?

News Daily News

Debating the ARB/MI Paradox: Is It Real, or Is the Story Incomplete?

Michael O'Riordan

June 05, 2017

FOURIER: Evolocumab Reduces Risk of CVD Events by 15% Compared With Placebo

News Conference News ACC 2017

FOURIER: Evolocumab Reduces Risk of CVD Events by 15% Compared With Placebo

Michael O'Riordan

March 17, 2017

News Daily News

Even With Early Invasive Strategy in NSTE ACS, Women Face Poorer Outcomes Than Men

January 24, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.